» Articles » PMID: 36222195

Suramin Enhances Chondrogenic Properties by Regulating the P67/PI3K/AKT/SOX9 Signalling Pathway

Overview
Journal Bone Joint Res
Date 2022 Oct 12
PMID 36222195
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Autologous chondrocyte implantation (ACI) is a promising treatment for articular cartilage degeneration and injury; however, it requires a large number of human hyaline chondrocytes, which often undergo dedifferentiation during in vitro expansion. This study aimed to investigate the effect of suramin on chondrocyte differentiation and its underlying mechanism.

Methods: Porcine chondrocytes were treated with vehicle or various doses of suramin. The expression of collagen, type II, alpha 1 (COL2A1), aggrecan (ACAN); COL1A1; COL10A1; SRY-box transcription factor 9 (SOX9); nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX); interleukin (IL)-1β; tumour necrosis factor alpha (TNFα); IL-8; and matrix metallopeptidase 13 (MMP-13) in chondrocytes at both messenger RNA (mRNA) and protein levels was determined by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and western blot. In addition, the supplementation of suramin to redifferentiation medium for the culture of expanded chondrocytes in 3D pellets was evaluated. Glycosaminoglycan (GAG) and collagen production were evaluated by biochemical analyses and immunofluorescence, as well as by immunohistochemistry. The expression of reactive oxygen species (ROS) and NOX activity were assessed by luciferase reporter gene assay, immunofluorescence analysis, and flow cytometry. Mutagenesis analysis, Alcian blue staining, reverse transcriptase polymerase chain reaction (RT-PCR), and western blot assay were used to determine whether p67 was involved in suramin-enhanced chondrocyte phenotype maintenance.

Results: Suramin enhanced the COL2A1 and ACAN expression and lowered COL1A1 synthesis. Also, in 3D pellet culture GAG and COL2A1 production was significantly higher in pellets consisting of chondrocytes expanded with suramin compared to controls. Surprisingly, suramin also increased ROS generation, which is largely caused by enhanced NOX (p67) activity and membrane translocation. Overexpression of p67 but not p67AD (deleting amino acid (a.a) 199 to 212) mutant, which does not support ROS production in chondrocytes, significantly enhanced chondrocyte phenotype maintenance, SOX9 expression, and AKT (S473) phosphorylation. Knockdown of p67 with its specific short hairpin (sh) RNA (shRNA) abolished the suramin-induced effects. Moreover, when these cells were treated with the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) inhibitor LY294002 or shRNA of AKT1, p67-induced COL2A1 and ACAN expression was significantly inhibited.

Conclusion: Suramin could redifferentiate dedifferentiated chondrocytes dependent on p67 activation, which is mediated by the PI3K/AKT/SOX9 signalling pathway.Cite this article:  2022;11(10):693-708.

Citing Articles

Identification of cell-specific epigenetic patterns associated with chondroitin sulfate treatment response in an endemic arthritis, Kashin-Beck disease.

Cheng B, Wu C, Wei W, Niu H, Wen Y, Li C Bone Joint Res. 2024; 13(5):237-246.

PMID: 38754865 PMC: 11098597. DOI: 10.1302/2046-3758.135.BJR-2023-0271.R1.


The Association between NADPH Oxidase 2 (NOX2) and Drug Resistance in Cancer.

Dong S, Chen C, Di C, Wang S, Dong Q, Lin W Curr Cancer Drug Targets. 2024; 24(12):1195-1212.

PMID: 38362697 DOI: 10.2174/0115680096277328240110062433.


The role of EDIL3 in maintaining cartilage extracellular matrix and inhibiting osteoarthritis development.

Chen M, Hu C, Hsu Y, Lin Y, Chen K, Ueng S Bone Joint Res. 2023; 12(12):734-746.

PMID: 38081212 PMC: 10713244. DOI: 10.1302/2046-3758.1212.BJR-2023-0087.R1.


Identification and experimental validation of key extracellular proteins as potential targets in intervertebral disc degeneration.

Zhang G, Li L, Luo Z, Zhang C, Wang Y, Kang X Bone Joint Res. 2023; 12(9):522-535.

PMID: 37661086 PMC: 10475329. DOI: 10.1302/2046-3758.129.BJR-2022-0369.R2.


Dihydrocaffeic acid improves IL-1β-induced inflammation and cartilage degradation via inhibiting NF-κB and MAPK signalling pathways.

Lu R, Wang Y, Qu Y, Wang S, Peng C, You H Bone Joint Res. 2023; 12(4):259-273.

PMID: 37492935 PMC: 10076109. DOI: 10.1302/2046-3758.124.BJR-2022-0384.R1.


References
1.
McGeary R, Bennett A, Tran Q, Cosgrove K, Ross B . Suramin: clinical uses and structure-activity relationships. Mini Rev Med Chem. 2008; 8(13):1384-94. DOI: 10.2174/138955708786369573. View

2.
Liu Q, He F, Zhou P, Xie M, Wang H, Yang H . HMGB2 promotes chondrocyte proliferation under negative pressure through the phosphorylation of AKT. Biochim Biophys Acta Mol Cell Res. 2021; 1868(11):119115. DOI: 10.1016/j.bbamcr.2021.119115. View

3.
Frisbie D, Bowman S, Colhoun H, DiCarlo E, Kawcak C, McIlwraith C . Evaluation of autologous chondrocyte transplantation via a collagen membrane in equine articular defects: results at 12 and 18 months. Osteoarthritis Cartilage. 2007; 16(6):667-79. DOI: 10.1016/j.joca.2007.09.013. View

4.
Ambe K, Watanabe H, Takahashi S, Nakagawa T . Immunohistochemical localization of Nox1, Nox4 and Mn-SOD in mouse femur during endochondral ossification. Tissue Cell. 2014; 46(6):433-8. DOI: 10.1016/j.tice.2014.07.005. View

5.
Liu Z, Tseng H, Tsai H, Su F, Huang H . Transforming growth factor β-interacting factor-induced malignant progression of hepatocellular carcinoma cells depends on superoxide production from Nox4. Free Radic Biol Med. 2015; 84:54-64. DOI: 10.1016/j.freeradbiomed.2015.03.028. View